Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Biopsy devices market analysis 2036: explore cancer diagnostics trends, device forecasts, intervention volumes, pricing analysis, reimbursement insights, and competitive market dynamics.
Why Does the Biopsy Devices Market Matter?
Biopsy devices play an important role in tissue sampling and diagnosis, with growing cancer incidence supporting demand across diagnostic procedures. The market also serves non-cancer indications, including chronic kidney disease, liver cirrhosis, and kidney and liver transplantations.
This report provides a comprehensive view of the global biopsy devices market, combining epidemiology-based indications, intervention volumes, market sizing, pricing, competitive analysis, reimbursement, and regulatory insights across 39 countries.
You can use this report to:
- Assess global, regional, and country-level biopsy device market trends
- Track market revenue, intervention volumes, units, and average selling prices
- Evaluate performance across key biopsy device segments
- Understand the impact of cancer and non-cancer indications on demand
- Benchmark leading companies and market shares
- Assess country-specific reimbursement and regulatory environments
- Identify opportunities for investment, partnerships, and market expansion

Key Insights in the Biopsy Devices Market
The report highlights key trends shaping the market, including:
- Increasing cancer incidence as a primary driver of biopsy device demand
- Biopsy applications across cancer and selected non-cancer indications
- Coverage of biopsy guns, vacuum-assisted needle devices, biopsy forceps, biopsy punches, and biopsy needles
- Market revenue and outlook by segment from 2015–2036
- Intervention volumes, units, market values, and average selling prices
- Global, regional, and country-specific market trends
- Competitive dynamics and market share analysis
- Country-specific reimbursement policies and medtech regulations
- Healthcare system factors influencing market access
- Emerging competitive developments across the biopsy devices landscape
Scope
What Will You Learn from This Biopsy Devices Market Report?
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –
– CMO executives who must have deep understanding of the Biopsy Devices marketplace to make strategic planning and investment decisions.
– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
Benchmark the Global Biopsy Devices Market
This report enables stakeholders to benchmark:
- Market revenue by device segment
- Intervention and unit volumes
- Average selling prices
- Market values and growth outlook
- Product usage across countries
- Company market shares and rankings
- Cancer and non-cancer indications
- Regional and country-level market performance
- Reimbursement policies
- Medtech regulatory environments
- Competitive dynamics across 39 countries
Built on GlobalData Medtech Intelligence
The market model integrates demand- and supply-side primary research, including insights from Key Opinion Leaders, with real-world data from government procedure databases, hospital purchasing databases, and proprietary online sources.
GlobalData’s analysts combine quantitative market models with qualitative insights to provide context on market trends, competitive dynamics, healthcare systems, reimbursement, and regulation.
Act Now to Identify Opportunities in the Biopsy Devices Market
With cancer incidence and biopsy interventions shaping demand, understanding where market growth, competitive opportunities, and changing healthcare environments are emerging is critical.
Use this report to track market performance through 2036, benchmark leading companies, identify attractive segments and countries, assess market access conditions, and support strategic investment, commercial, and partnership decisions.
Devicor Medical Products Inc
Hologic Inc
Wilson-Cook Medical Inc
Boston Scientific Corp
Medtronic Plc
CONMED Corp
Olympus Corp
Argon Medical Devices Inc
Henry Schein Inc
Coloplast A/S
Merit Medical Systems Inc
Integra LifeSciences Holdings Corp
Teleflex Inc
Acuderm Inc
United States Endoscopy Group Inc
Others
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more General Surgery reports

